Cargando…
Efficacy and Safety of Amrubicin in Small Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors and Chemotherapy
SIMPLE SUMMARY: Therapeutic efficacy of chemotherapy combined with immune checkpoint inhibitors as first-line therapy has been previously demonstrated in extensive-stage small cell lung cancer. However, there are no reports of any cytotoxic drug that is effective as second-line therapy in extensive-...
Autores principales: | Nishimura, Tadashi, Fujimoto, Hajime, Fujiwara, Takumi, Ito, Kentaro, Fujiwara, Atsushi, Yuda, Hisamichi, Itani, Hidetoshi, Naito, Masahiro, Kodama, Shuji, Yagi, Akihiko, D’Alessandro, Valeria Fridman, Yasuma, Taro, Furuhashi, Kazuki, Saiki, Haruko, Okano, Tomohito, Tomaru, Atsushi, Tanigawa, Motoaki, D’Alessandro-Gabazza, Corina N., Gabazza, Esteban C., Yoshida, Masamichi, Hataji, Osamu, Ibata, Hidenori, Kobayashi, Tetsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406319/ https://www.ncbi.nlm.nih.gov/pubmed/36010946 http://dx.doi.org/10.3390/cancers14163953 |
Ejemplares similares
-
De Novo T790M Mutation in an L858R Epidermal Growth Factor Receptor Mutant-Associated Lung Adenocarcinoma
por: Fujiwara, Takumi, et al.
Publicado: (2020) -
Low-Dose of Intrapulmonary Pirfenidone Improves Human Transforming Growth Factorβ1-Driven Lung Fibrosis
por: Okano, Tomohito, et al.
Publicado: (2020) -
Amelioration of Pulmonary Fibrosis by Matrix Metalloproteinase-2 Overexpression
por: Inoue, Ryo, et al.
Publicado: (2023) -
No Strong Evidence for Ruling Out the Role of Coagulation in Long-Term Disability after Critical Illness
por: Yasuma, Taro, et al.
Publicado: (2021) -
A Retrospective Comparison of the Clinical Efficacy of Gefitinib, Erlotinib, and Afatinib in Japanese Patients With Non-Small Cell Lung Cancer
por: Fujiwara, Atsushi, et al.
Publicado: (2018)